Expanded Coverage of Species Aids Disease Research and Agricultural Studies

CARLSBAD, Calif.–Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced the release of a new set of genomic analysis tools to aid disease research and agricultural studies. These tools are available through the latest release of the TaqMan® Gene Expression Assays product line to evaluate levels of RNA expression in model organisms including cows, chickens, horses, pigs, rabbits, and rice.

These new pre-designed TaqMan assays will allow researchers to expand their applications of real-time PCR-based gene expression analysis. The assays will enable genomic analysis of plants for agricultural studies to improve crop yield and of animals for herd management. Also, assays for species such as chickens, rabbits, pigs, and cattle will help to advance both animal and human disease research.

For example, scientists at Michigan State University are applying RNA expression analysis to study mastitis, a disease that frequently afflicts dairy cattle, costing farmers billions of dollars a year. This team of researchers is using Custom TaqMan® Gene Expression Assays to characterize genes involved with tissue inflammation associated with this disease. They have also been able to use the cow as a model for studying the genetic basis of inflammation in human diseases such as cardiovascular disease.

The newest release of TaqMan Gene Expression Assays broadens Applied Biosystems’ collection of more than 1 million pre-designed assays across 15 different species. Applied Biosystems will continue to add to its catalog of pre-designed assays for species and organisms relevant to critical research applications. TaqMan Gene Expression Assays are available through Applied Biosystems’ website.

Lorraine Sordillo, Ph.D., a Veterinary Immunologist, College of Veterinary Medicine at Michigan State University

“Evaluating the meaning of quantitative changes in gene expression will provide valuable insights into molecular mechanisms underlying the process of inflammation. The pre-designed TaqMan Gene Expression Assays for bovines will make it easier for us to characterize functionally important genes for diseases affecting cattle and humans and give us confidence in the accuracy of our data.”

Sam Raha, Vice President of Applied Biosystems’ Genomic Assays Business at Life Technologies

“By expanding the species coverage in our portfolio of gold-standard TaqMan Gene Expression Assays, we are providing more scientists with access to technology that gives high-confidence results and accelerates their research. These new molecular tools are part of our ongoing commitment to apply our assay design expertise to help scientists focus on their biological research instead of technology development.”

Applied Biosystems Leadership in Molecular Biology Systems

Applied Biosystems is a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis. It is a market leader in RNA expression analysis tools that include a complete line of TaqMan assays and arrays, and a family of real-time PCR systems. Applied Biosystems, along with Invitrogen – a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics – is part of Life Technologies. Together, Applied Biosystems and Invitrogen provide the broadest portfolio of RNA analysis tools available from a single company. Applied Biosystems and Invitrogen products are used in nearly every major laboratory in the world.

For more information, please visit: www.appliedbiosystems.com and www.invitrogen.com.

About Life Technologies

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

For Research Use Only. Not for use in diagnostic procedures.

Copyright 2009. Life Technologies Corporation. All rights reserved. Applied Biosystems is a registered trademark of Life Technologies or its subsidiaries in the United States and/or certain other countries. TaqMan® is a registered trademark of Roche Molecular Systems, Inc.